BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

BioDrain Medical, Inc. Exhibits at National Registered Nurses Conference


2/26/2013 9:49:25 AM

MINNEAPOLIS, Feb. 26, 2013 /PRNewswire/ -- BioDrain Medical, Inc., (OTCQB: BIOR), producer of the FDA approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste, announced today that it will exhibit its breakthrough technology at the 60th Annual Association of periOperative Registered Nurses (AORN) Congress in San Diego in March.

BioDrain will showcase the Company's groundbreaking FDA approved STREAMWAY System from March 4 6, 2013 at the San Diego Convention Center in San Diego, California at booth #1520.

Today's manual surgical fluid handling method, which means hand-carrying surgical fluid canisters and emptying these canisters into drains and sinks, creates a great exposure risk and is an antiquated approach to the handling of surgical fluid waste. BioDrain's STREAMWAY System is a direct-to-drain product that is a stationary system installed into each surgical room and hooked into a hospital's existing drain and vacuum system. Unlike other fluid management options, the STREAMWAY System has continuous suction and unlimited capacity.

"We are experiencing a rapid upswing in awareness about our flagship technology as hospitals search for safer and more efficient ways to dispose of surgical fluids. Demonstrating the STREAMWAY System at the AORN Congress is a great opportunity to share this technology with the healthcare personnel who are on the front lines when it comes to removing surgical waste after procedures," said Josh Kornberg, Chief Executive Officer at BioDrain Medical. "These are the people who will truly understand the impact of an automated direct-to-drain system for them it means less time and less risk of exposure to potentially dangerous materials."

"The feedback we get from nurses and doctors is resoundingly positive. The STREAMWAY System improves operating room safety by offering a cleaner, safer surgical fluid disposal solution that is more reliable and less expensive than the existing manual processes," continued Mr. Kornberg. "In fact, 100 percent of our trial installations have resulted in a sale of the system, so we believe that offering AORN Congress participants the chance to interface with the technology will help thousands of healthcare leaders realize the positive impact the STREAMWAY System can have on their practicesin terms of budget, safety, ease-of-use and environmental mindfulness."

For additional information about the Company, please visit: www.biodrainmedical.com.

About BioDrain Medical
BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids and is designed to result in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving Occupational State and Health Association (OSHA) and other regulatory compliance agencies' safety concerns, and 3) streamlining the efficiency of the operating room (and thereby making surgeries more profitable).

BioDrain's STREAMWAY System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain's STREAMWAY System, the number of canisters can be significantly reduced. BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.biodrainmedical.com.

Forward-looking Statements
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the company's most recent Quarterly Report on Form 10-Q and subsequent 8-K filings.

Public Relations Contact:
Samantha Wolf
KCSA Strategic Communications
212-896-1220
swolf@kcsa.com

Investor Relations Contact:
Phil Carlson
KCSA Strategic Communications
212-896-1233
pcarslon@kcsa.com

SOURCE BioDrain Medical



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->